Stock ALTME TME PHARMA N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart TME Pharma N.V.

Equities

ALTME

NL0015000YE1

Market Closed - Euronext Paris
Other stock markets
 11:35:07 2024-06-05 am EDT 		5-day change 1st Jan Change
0.2365 EUR -2.47% Intraday chart for TME Pharma N.V. -5.21% +2.83%
Apr. 25 TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 23 TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
TME PHARMA N.V. Stock TME Pharma N.V.
 7.5M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 55.7B -
LONZA GROUP AG Stock Lonza Group AG
 39.91B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.57B
CELLTRION, INC. Stock Celltrion, Inc.
 28.16B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.3B
  1. Stock Market
  2. Equities
  3. ALTME Stock
  4. Charts TME Pharma N.V.
  5. Sector Chart